CAPTRUST Financial Advisors
CODX

CAPTRUST Financial Advisors’s Co-Diagnostics CODX Stock Holding History

CAPTRUST Financial Advisors’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3
Closed -$1K – 4780
2021
Q3 		$1K Sell
3
-2
-40% -$584 ﹤0.01% 4409
2021
Q2 		$1K Buy
5
+3
+150% +$771 ﹤0.01% 4315
2021
Q1 		$1K Sell
2
-15
-88% -$5.99K ﹤0.01% 4174
2020
Q4 		$5K Hold
17
– – ﹤0.01% 2835
2020
Q3 		$6K Hold
17
– – ﹤0.01% 2469
2020
Q2 		$10K Buy
+17
New +$7.76K ﹤0.01% 2173

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
ARC
Advisor Resource Council Dallas, Texas $309M AUM 22.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CAPTRUST Financial Advisors's CODX Position: Q4 2021 in Review

CAPTRUST Financial Advisors sold out of Co-Diagnostics (CODX) in Q4 2021, closing a stake of 3 shares — an estimated $1K sold.

CAPTRUST Financial Advisors first reported a position in CODX in Q2 2020 and held it in 6 quarters. The position peaked at $10K in Q2 2020. 77 funds tracked by Wall St. Rank hold CODX as of Q4 2021.

  • CAPTRUST Financial Advisors reported no remaining Co-Diagnostics position as of Q4 2021 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 3 Co-Diagnostics shares in Q4 2021, an estimated $1K.
  • CAPTRUST Financial Advisors first reported a position in Co-Diagnostics in Q2 2020 and held it in 6 quarters.
  • CAPTRUST Financial Advisors's Co-Diagnostics position peaked at $10K in Q2 2020.
  • 77 funds tracked by Wall St. Rank held Co-Diagnostics as of Q4 2021.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.